-+ 0.00%
-+ 0.00%
-+ 0.00%

SCIENTURE ANNOUNCES MANUFACTURING AND SUPPLY CHAIN READINESS FOR ARBLITM, (LOSARTAN POTASSIUM) ORAL SUSPENSION, 10MG/ML FOR A TARGET PRODUCT LAUNCH IN JULY 2025.

Reuters·04/22/2025 12:04:59

Please log in to view news